# Impruvon, Inc. — Form D

Impruvon, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-05. The offering totals $2.5M, of which $2.4M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2025-02-05
- Form: D
- Accession: 0002052407-25-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.4M
- Remaining: $85K
- Investors: 14
- Date of first sale: 2024-11-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-537357

## Issuer

- Name: Impruvon, Inc.
- CIK: 0002052407
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 2101 E. BIDDLE STREET, BALTIMORE, MD, 21213
- Phone: 410-818-7272

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Justin Amoyal | Director | Baltimore, MD |
| Matthew Brezina | Director | San Francisco, CA |
| Christopher College | Director | Baltimore, MD |
| Justin Amoyal | Executive Officer | Baltimore, MD |
| Justin Amoyal | Promoter | Baltimore, MD |

## More

- [CIK 2052407 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2052407&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002052407-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.